Veradermics’s drug, a pill version of the topical hair loss product minoxidil, was developed with technology intended to avoid the cardiovascular risks associated with oral dosing of this compound. The first of three pivotal clinical trials is expected to yield preliminary data in the first half of 2026. The post Baldness Biotech Veradermics Prices $256M…
From Coby Lefkowitz in Building Optimism: In Los Angeles, “luxury” units in non-high-rises can be delivered for around $300,000 to $400,000 per unit. Non-“luxury” market rate units can be completed for half of that, conditional on their size and location. Capital “A” Affordable units, on the other hand, can cost more than $850,000 for what…
Maria Tabarez, Director of Facilities, Exodus Recovery Safe Landing Maria Tabarez has an unusual job: maintaining, cleaning, and disinfecting a 172-bed homeless shelter. The challenges of keeping the five-building facility clean and disinfected 24/7 present challenges unlike most other Crothall facilities. Some residents who come to Exodus Recovery Safe Landing in Los Angeles have more…
Fortina Hernández is called “the one who knows it all.” For more than two decades, the community health worker has supported hundreds of families throughout southeast Los Angeles by helping them sign up for food assistance, sharing information about affordable health coverage, and managing medications for their chronic illnesses. She’s guided by the expression “an…
COLUMBUS, Miss. — April Hines has battled with her weight since she was a teenager. But in the past couple of years, she’s fallen from 600 pounds to 385, and her blood pressure and blood sugar levels are down, too. “I’m not as fatigued as I used to be, and I’ve been able to go…
SACRAMENTO, Calif. — California public health officials are dipping into state and federal stockpiles to equip up to 10,000 farmworkers with masks, gloves, goggles, and other safety gear as the state confirms at least 21 human cases of bird flu as of early November. It’s the latest reminder of the state’s struggle to remain prepared…
Novartis is getting Tourmaline Bio’s pacibekitug, a Phase 3-ready antibody drug in development for atherosclerotic cardiovascular disease (ASCVD). Tourmaline licensed pacibekitug from Pfizer, which remains eligible for milestone payments tied to the progress of the drug. The post Novartis’s $1.4B Tourmaline Acquisition Brings Heart Drug That Could Rival Novo Nordisk, CSL Meds appeared first on…
[Sponsored] Megan Zakrewsky, vice president of product at Veradigm talks about how the company is utizing tech among providers, payers and patients. Watch now! The post MedCity Pivot: How Veradigm Aims to Close the Information Gap appeared first on MedCity News.
Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for the worse if the incoming Trump administration veered away from accepted norms regarding vaccines. The post Pfizer CEO At JPM Issues Clear Warning to Kennedy on Vaccines appeared first on MedCity News.
If you thought that Big Pharma and the PBMs were the only bad guys in the saga of unreasonably high prescription drug prices in the United States, you would be wrong. Hear who else is to blame from the CEO of Blue Shield of California. The post Video: Besides, Pharma and PBMs, Who Drives Up…